Nano Chem Tech Reports Q1 2026: Revenue ₩8.56B, Operating Loss ₩7.03B, Continued Losses and Deteriorating Financial Health

Q1 2026 consolidated revenue ₩8.56 billion, operating loss ₩7.03 billion, net loss ₩1.56 billion (revenue similar to prior year, operating loss widened).
Debt ratio 228%, consolidated equity ₩21.7 billion, accumulated deficit ₩53.5 billion, weak financial structure.
Total financial liabilities ₩49.1 billion (current ₩35.3 billion, non-current ₩14.3 billion) with ₩24.9 billion maturing within one year, liquidity burden.
Derivative liabilities (CB valuation) of ₩6.06 billion.
Cash and cash equivalents of ₩9.2 billion.
Key changes: Early redemption and cancellation of 12th CB (₩3 billion) in Jan 2026; cancellation of DB Investment Fund stake sale agreement (Jan 2026); ongoing share transfer of Canvas Inc.
Held 18% stake in Hanil Onics after selling 29% (remaining 18% disposed as of Dec 31, 2025).